Wanda K. Jones

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 851 citations

Surgical Oncology, Overall Response Rates, Cisplatin Programs +12

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Maurie Markman, Eric K. Rowinsky, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1992 · 313 citations

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

Maurie Markman, Bonnie Reichman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 190 citations

Surgical Oncology, Intravenous Cisplatin, Ip Cisplatin Initiation +14

On-site, rapid HIV testing with same-day results and counseling

William J. Kassler, Beth Dillon, Charles Haley et al. · AIDS · 1997 · 162 citations

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

M Markman, Thomas B. Hakes, Bonnie Reichman et al. · Journal of Clinical Oncology · 1992 · 135 citations